Back to Mobile View

boehringer

Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II trial. It also said that a Phase I trial showed the drug induced durable remission in patients with non-Hodgkin lymphoma.
The pharmaceutical industry has discovered the female libido. German biotech company Boehringer Ingelheim is "putting the finishing touches on a pill designed to reawaken desire by blunting female inhibitions," according to Bloomberg News, which scientists will discuss next week in Lyon,...
AstraZeneca (AZN) has long hoped that its blood-thinner drug Brilinta was going to become a blockbuster. From the looks of things, the company may gets its wish. Back in May, the pharmaceutical company announced that its experimental heart drug Brilinta was more effective than Sanofi-Aventis...

Market Movers

SymbolLastChange / %Volume

Most Actives

BAC
Bank of America Corp
8.10-0.09
-1.04%
158.19M
ALU
Alcatel-Lucent (ADR)
2.20+0.26
+13.14%
95.52M
GE
General Electric Company
18.90-0.24
-1.23%
26.45M
F
Ford
12.41-0.28
-2.21%
25.99M

% Gainers

CIE
Cobalt International Energy
32.62 +8.72
+36.49%
14.25M
LNKD
LinkedIn Corp.
89.53 +13.14
+17.20%
9.05M
ALU
Alcatel-Lucent (ADR)
2.20 +0.26
+13.14%
95.52M
WNS
WNS (Holdings) Limited (ADR)
10.52 +1.12
+11.91%
2.68M

% Losers

KV-A
K V Pharmaceutical Co. Class A
2.10-0.51
-19.54%
1.45M
KV-B
K-V Pharmaceutical Co. Class B
2.16-0.47
-17.87%
4,779
NBG-A
National Bank of Greece SA (ADR)
5.74-1.01
-14.96%
125,314
OSG
Overseas Shipholding Group, Inc.
10.43-1.40
-11.83%
1.35M
Newswire

Follow Us

Headlines From DailyFinance Partners

CNN Money
CNBC
Smart Money
Consumer Reports
Huffington Post
AOL Energy
AOL Jobs
Business News Personal Finance Investing Our Partners

DailyFinance Sitemap | Terms of Service | Privacy Policy | Trademarks | HELP | Advertise With Us

© Copyright 2012 AOL Inc. All Rights Reserved